Effects of single green tea ingestion on pharmacokinetics of nadolol in healthy volunteers.

epigallocatechin gallate food-drug interaction green tea nadolol pharmacokinetics

Journal

British journal of clinical pharmacology
ISSN: 1365-2125
Titre abrégé: Br J Clin Pharmacol
Pays: England
ID NLM: 7503323

Informations de publication

Date de publication:
11 2020
Historique:
received: 01 12 2019
revised: 19 03 2020
accepted: 02 04 2020
pubmed: 23 4 2020
medline: 29 7 2021
entrez: 23 4 2020
Statut: ppublish

Résumé

The aim of this study was to investigate the effects of a single green tea (GT), administered concomitantly or 1 hour before nadolol intake on nadolol pharmacokinetics. In a randomized 3-phase crossover study, 11 healthy volunteers received an oral administration of nadolol with, or 1 hour after preingestion of brewed GT, or with water in a volume of 150 mL. Geometric mean ratio with 90% confidence interval for nadolol AUC These results suggest that single concomitant ingestion of GT substantially decreases plasma concentrations of nadolol. Moreover, the reduction in nadolol bioavailability could persist for at least 1 hour after drinking a cup of GT.

Identifiants

pubmed: 32320490
doi: 10.1111/bcp.14315
pmc: PMC7576630
doi:

Substances chimiques

Tea 0
Nadolol 42200-33-9
Catechin 8R1V1STN48

Types de publication

Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2314-2318

Subventions

Organisme : JSPS KAKENHI
ID : JP17K17983
Organisme : Honjo International Scholarship Foundation (Food and Health Program 2015), Tokyo, Japan

Informations de copyright

© 2020 The British Pharmacological Society.

Références

J Agric Food Chem. 2007 Jun 27;55(13):4957-64
pubmed: 17530772
Drug Metab Dispos. 2020 Apr;48(4):245-254
pubmed: 31959703
Biochim Biophys Acta. 2002 Jan 30;1542(1-3):149-59
pubmed: 11853888
Eur J Clin Pharmacol. 2018 Jun;74(6):775-783
pubmed: 29480324
Biochem Pharmacol. 2011 Dec 15;82(12):1807-21
pubmed: 21827739
Drug Metab Dispos. 2006 Apr;34(4):577-82
pubmed: 16415120
Drug Metab Dispos. 2011 May;39(5):920-6
pubmed: 21278283
Eur J Clin Pharmacol. 2018 May;74(5):601-609
pubmed: 29368187
Drug Metab Pharmacokinet. 2013;28(3):244-9
pubmed: 23268924
Clin Pharmacol Ther. 2007 Mar;81(3):362-70
pubmed: 17215845
Br J Clin Pharmacol. 2020 Nov;86(11):2314-2318
pubmed: 32320490
J Clin Pharmacol. 2013 Jul;53(7):738-45
pubmed: 23677858
Clin Pharmacol Ther. 2014 Apr;95(4):432-8
pubmed: 24419562
Mutat Res. 2001 Aug 8;479(1-2):197-206
pubmed: 11470492
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Apr 13;834(1-2):26-34
pubmed: 16513433
Clin Pharmacol Ther. 1980 Jan;27(1):57-63
pubmed: 6101312
PLoS One. 2015 Oct 01;10(10):e0139370
pubmed: 26426900

Auteurs

Shingen Misaka (S)

Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.

Osamu Abe (O)

Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.
Department of Neuropsychiatry, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.

Tomoyuki Ono (T)

Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.

Yuko Ono (Y)

Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.

Hiroshi Ogata (H)

Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.

Itaru Miura (I)

Department of Neuropsychiatry, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.

Yayoi Shikama (Y)

Centre for Medical Education and Career Development, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.

Martin F Fromm (MF)

Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Hirooki Yabe (H)

Department of Neuropsychiatry, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.

Kenju Shimomura (K)

Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH